LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 388

Suchoptionen

  1. Artikel ; Online: Cancer screening in people living with HIV.

    Masiá, Mar / Gutiérrez-Ortiz de la Tabla, Ana / Gutiérrez, Félix

    Cancer medicine

    2023  Band 12, Heft 21, Seite(n) 20590–20603

    Abstract: Background: Cancer is the leading cause of mortality in people living with HIV (PWH) and is expected to account for a growing fraction of deaths as PWH age.: Methods: In this literature review, we have compiled the most recent developments in cancer ... ...

    Abstract Background: Cancer is the leading cause of mortality in people living with HIV (PWH) and is expected to account for a growing fraction of deaths as PWH age.
    Methods: In this literature review, we have compiled the most recent developments in cancer screening and screening performance in PWH, which are currently primarily implemented in well-resourced settings. This includes an assessment of the associated benefits, harms, and cost-effectiveness. The article also addresses unmet needs and potential strategies for tailored screening in the HIV population.
    Findings: Incidence and mortality due to screenable cancer are higher in PWH than in the general population, and diagnosis is frequently made at younger ages and/or at more advanced stages, the latter amenable to improved screening. Adequate evidence on the benefits of screening is lacking for most cancers in the HIV population, in whom standard practice may be suboptimal. While cancer surveillance has helped reduce mortality in the general population, and interest in risk-based strategies is growing, implementation of screening programs in the HIV care settings remains low.
    Interpretation: Given the devastating consequences of a late diagnosis, enhancing early detection of cancer is essential for improving patient outcomes. There is an urgent need to extend the investigation in cancer screening performance to PWH, evaluating whether personalized measures according to individual risk could result in higher efficiency and improve patient outcomes.
    Mesh-Begriff(e) Humans ; Early Detection of Cancer ; Incidence ; HIV Infections/complications ; HIV Infections/diagnosis ; HIV Infections/epidemiology ; Neoplasms/diagnosis ; Neoplasms/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2023-10-25
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2659751-2
    ISSN 2045-7634 ; 2045-7634
    ISSN (online) 2045-7634
    ISSN 2045-7634
    DOI 10.1002/cam4.6585
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Cancer screening in people with HIV: Implementation in clinical practice and barriers perceived by medical specialists in Spain.

    Gutiérrez, Félix / Padilla, Sergio / García-Abellán, Javier / Gutiérrez-Ortiz de la Tabla, Ana / Ledesma, Christian / Masiá, Mar

    Enfermedades infecciosas y microbiologia clinica (English ed.)

    2024  

    Abstract: Objective: To assess the degree of implementation of cancer screening recommendations in people living with HIV (PLHIV) in Spain.: Methods: A self-administered questionnaire was designed on the strategies used for early detection of the main types of ...

    Abstract Objective: To assess the degree of implementation of cancer screening recommendations in people living with HIV (PLHIV) in Spain.
    Methods: A self-administered questionnaire was designed on the strategies used for early detection of the main types of cancer in PLHIV. The survey was distributed electronically to HIV physicians participating in the Spanish CoRIS cohort.
    Results: 106 questionnaires were received from 12 different Spanish Autonomous Communities, with an overall response rate among those who accessed the questionnaire of 60.2%. The majority responded that they followed the CPGs recommendations for the early detection of liver (94.3%), cervical (93.2%) and breast (85.8%) cancers. In colorectal and anal cancer, the proportion was 68.9% and 63.2%, and in prostate and lung cancer of 46.2% and 19.8%, respectively. In hospitals with a greater number of beds, a tendency to perform more cancer screening and greater participation of the Infectious Diseases/HIV Services in the screening programmes was observed. Significant differences were observed in the frequency of colorectal and anal cancer screening among the different Autonomous Communities. The most frequent reasons for not performing screening were the scarcity of material and/or human resources and not being aware of what is recommended in the CPGs.
    Conclusions: There are barriers and opportunities to expand cancer screening programmes in PLHIV, especially in colorectal, anal and lung cancers. It is necessary to allocate resources for the early detection of cancer in PLHIV, but also to disseminate CPGs screening recommendations among medical specialists.
    Sprache Englisch
    Erscheinungsdatum 2024-01-22
    Erscheinungsland Spain
    Dokumenttyp Journal Article
    ISSN 2529-993X
    ISSN (online) 2529-993X
    DOI 10.1016/j.eimce.2024.01.007
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Dyspnea and pleuritic chest pain during the COVID-19 pandemic.

    Guillén, Lucía / Telenti, Guillermo / Botella, Ángela / Masiá, Mar

    Enfermedades infecciosas y microbiologia clinica (English ed.)

    2020  Band 39, Heft 1, Seite(n) 41–42

    Mesh-Begriff(e) COVID-19/complications ; COVID-19/diagnosis ; Chest Pain/etiology ; Dyspnea/etiology ; Humans ; Male ; Middle Aged ; Pleurisy/etiology
    Schlagwörter covid19
    Sprache Spanisch
    Erscheinungsdatum 2020-07-04
    Erscheinungsland Spain
    Dokumenttyp Case Reports ; Journal Article
    ISSN 2529-993X
    ISSN (online) 2529-993X
    DOI 10.1016/j.eimc.2020.06.009
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Long COVID across SARS-CoV-2 variants, lineages, and sublineages.

    Padilla, Sergio / Ledesma, Christian / García-Abellán, Javier / García, José Alberto / Fernández-González, Marta / de la Rica, Alba / Galiana, Antonio / Gutiérrez, Félix / Masiá, Mar

    iScience

    2024  Band 27, Heft 4, Seite(n) 109536

    Abstract: This prospective study aimed to determine the prevalence of long COVID in patients hospitalized for SARS-CoV-2 infection from March 2020 to July 2022 and assess the impact of different viral lineages. A total of 2,524 patients were followed up for 12 ... ...

    Abstract This prospective study aimed to determine the prevalence of long COVID in patients hospitalized for SARS-CoV-2 infection from March 2020 to July 2022 and assess the impact of different viral lineages. A total of 2,524 patients were followed up for 12 months, with persistent symptoms reported in 35.2% at one month, decreasing thereafter. Omicron variant patients initially showed higher symptom intensity, but this trend diminished over time. Certain viral lineages, notably Delta lineages AY.126 and AY.43, and Omicron sublineages BA.1.17, BA.2.56, and BA.5.1, consistently correlated with more severe symptoms. Overall, long COVID prevalence and severity were similar across SARS-CoV-2 variants. Specific lineages may influence post-COVID sequelae persistence and severity.
    Sprache Englisch
    Erscheinungsdatum 2024-03-19
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2024.109536
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Incidence of delayed asymptomatic COVID-19 recurrences in a 6-month longitudinal study.

    Masiá, Mar / Padilla, Sergio / Galiana, Antonio / Fernández-González, Marta / Gutiérrez, Félix

    The Journal of infection

    2021  Band 82, Heft 6, Seite(n) 276–316

    Mesh-Begriff(e) COVID-19 ; Humans ; Incidence ; Longitudinal Studies ; Recurrence ; Reinfection ; SARS-CoV-2
    Sprache Englisch
    Erscheinungsdatum 2021-03-29
    Erscheinungsland England
    Dokumenttyp Letter ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2021.03.020
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Environmental Microplastics in the Lower Airway of Shoe Manufacturing Workers.

    Baeza-Martínez, Carlos / Zamora-Molina, Lucía / Garcia-Pachon, Eduardo / Masiá, Mar / Hernandez-Blasco, Luis / Bayo, Javier

    Open respiratory archives

    2022  Band 4, Heft 4, Seite(n) 100209

    Sprache Englisch
    Erscheinungsdatum 2022-09-16
    Erscheinungsland Spain
    Dokumenttyp Case Reports
    ISSN 2659-6636
    ISSN (online) 2659-6636
    DOI 10.1016/j.opresp.2022.100209
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel: Dyspnea and pleuritic chest pain during the COVID-19 pandemic

    Guillén, Lucía / Telenti, Guillermo / Botella, Ángela / Masiá, Mar

    Enferm. infecc. microbiol. clin. (Ed. impr.)

    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #624006
    Datenquelle COVID19

    Kategorien

  8. Artikel ; Online: A Rapid, Convergent Approach to the Identification of Exosome Inhibitors in Breast Cancer Models.

    Andreu, Zoraida / Masiá, Esther / Charbonnier, David / Vicent, María J

    Nanotheranostics

    2023  Band 7, Heft 1, Seite(n) 1–21

    Abstract: Targeting cancer cell exosome release and biogenesis represents a potentially efficient means to treat tumors and prevent cancer recurrence/metastasis; however, the complexity and time-consuming nature of currently employed methods to purify and ... ...

    Abstract Targeting cancer cell exosome release and biogenesis represents a potentially efficient means to treat tumors and prevent cancer recurrence/metastasis; however, the complexity and time-consuming nature of currently employed methods to purify and characterize exosomes represent obstacles to progression. Herein, we describe a rapid, convergent, and cost-efficient strategy to analyze candidate U.S. Food and Drug Administration (FDA)-approved drugs that inhibit exosome release and/or biogenesis using breast cancer cell line models in the hope of repurposing them for the clinical treatment of metastatic tumors. We combined the ExoScreen assay based on AlphaScreen
    Mesh-Begriff(e) United States ; Humans ; Exosomes/metabolism ; Cell Line, Tumor ; MCF-7 Cells ; Neoplasms/metabolism
    Sprache Englisch
    Erscheinungsdatum 2023-01-01
    Erscheinungsland Australia
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2206-7418
    ISSN (online) 2206-7418
    DOI 10.7150/ntno.73606
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel: Autophagy in intestinal fibrosis: relevance in inflammatory bowel disease.

    Macias-Ceja, Dulce C / Barrachina, María D / Ortiz-Masià, Dolores

    Frontiers in pharmacology

    2023  Band 14, Seite(n) 1170436

    Abstract: Chronic inflammation is often associated with fibrotic disorders in which an excessive deposition of extracellular matrix is a hallmark. Long-term fibrosis starts with tissue hypofunction and finally ends in organ failure. Intestinal fibrosis is not an ... ...

    Abstract Chronic inflammation is often associated with fibrotic disorders in which an excessive deposition of extracellular matrix is a hallmark. Long-term fibrosis starts with tissue hypofunction and finally ends in organ failure. Intestinal fibrosis is not an exception, and it is a frequent complication of inflammatory bowel disease (IBD). Several studies have confirmed the link between deregulated autophagy and fibrosis and the presence of common prognostic markers; indeed, both up- and downregulation of autophagy are presumed to be implicated in the progression of fibrosis. A better knowledge of the role of autophagy in fibrosis may lead to it becoming a potential target of antifibrotic therapy. In this review we explore novel advances in the field that highlight the relevance of autophagy in fibrosis, and give special focus to fibrosis in IBD patients.
    Sprache Englisch
    Erscheinungsdatum 2023-06-15
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2023.1170436
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Human Immunodeficiency Virus Type 1 RNA Levels in Rectal and Seminal Compartments After Switching to Long-Acting Cabotegravir Plus Rilpivirine: A Longitudinal Study.

    Masiá, Mar / Fernández-González, Marta / Agulló, Vanesa / Mascarell, Paula / Padilla, Sergio / García-Abellán, Javier / Gutiérrez, Félix

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2022  Band 76, Heft 3, Seite(n) e748–e751

    Abstract: Human immunodeficiency virus type 1 RNA levels were longitudinally evaluated in 211 rectal and 152 seminal samples from 12 virologically suppressed participants switching to monthly long-acting cabotegravir plus rilpivirine or continuing with daily ... ...

    Abstract Human immunodeficiency virus type 1 RNA levels were longitudinally evaluated in 211 rectal and 152 seminal samples from 12 virologically suppressed participants switching to monthly long-acting cabotegravir plus rilpivirine or continuing with daily dolutegravir-abacavir-lamivudine. Maintenance of viral suppression in rectal and seminal compartments was comparable, and blips occurred with similar frequency with both treatment regimens.
    Clinical trials registration: NCT02938520.
    Mesh-Begriff(e) Humans ; Anti-HIV Agents/therapeutic use ; Anti-Retroviral Agents/therapeutic use ; HIV Infections/drug therapy ; HIV-1/genetics ; Longitudinal Studies ; Rilpivirine/therapeutic use ; RNA/therapeutic use
    Chemische Substanzen Anti-HIV Agents ; Anti-Retroviral Agents ; cabotegravir (HMH0132Z1Q) ; Rilpivirine (FI96A8X663) ; RNA (63231-63-0)
    Sprache Englisch
    Erscheinungsdatum 2022-08-16
    Erscheinungsland United States
    Dokumenttyp Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciac676
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang